TABLE 1.
Strain | yr of isolation | Phenotype | Origina | STb | O type | Resistance patternc | MIC (mg/L)d |
|
---|---|---|---|---|---|---|---|---|
CST | NAC | |||||||
PAO1 | 1954 | Nonmucoid | Wound | ST549 | O5 | Wild type | 2 | 64,000 |
Z33 | 2005 | Nonmucoid | CF | ST235 | O11 | CPr, FQr, AGr | 1 | 16,000 |
Z34 | 2006 | Nonmucoid | CF | ST17 | O1 | CBr, CPr, FQr, AGr | 2 | 64,000 |
Z35 | 2006 | Nonmucoid | CF | ST235 | O11 | 1 | 16,000 | |
Z152 | 2013 | Mucoid | CF | ST155 | O6 | CBr, FQr, AGr | 2 | 8,000 |
Z154 | 2016 | Mucoid | CF | ST412 | O6 | CPr, FQr, AGr | 2 | 16,000 |
M1 | 2002 | Mucoid | CF | ST155 | O6 | CBr, CPr, FQr, AGr | 2 | 16,000 |
M4 | 2005 | Mucoid | CF | ST155 | O6 | CBr, CPr, FQr, AGr | 2 | 32,000 |
M7 | 2005 | Mucoid | CF | ST253 | O10 | AGr | 2 | 64,000 |
M13 | 2000 | Mucoid | CF | ST274 | O3 | CBr, CPr, AGr | 1 | 32,000 |
M19 | 2006 | Mucoid | CF | ST3509 | O7 | 1 | 64,000 | |
M25 | 2002 | Mucoid | CF | ST235 | O11 | 2 | 16,000 | |
M32 | 2006 | Mucoid | CF | ST235 | O11 | 2 | 16,000 | |
M42 | 2007 | Mucoid | CF | ST2437 | O6 | CBr, CPr, FQr, AGr | 2 | 32,000 |
FC237 | 2007 | Nonmucoid | CF | ST365 | O3 | CBr, FQr, AGr, CSTr | 512 | 64,000 |
FC238 | 2007 | Nonmucoid | CF | ST910 | O6 | CBr, CSTr | 8 | 64,000 |
FZ99 | 2018 | Nonmucoid | RTIICU | ST111 | O12 | CBr, CPr, FQr, AGr, CSTr | 4 | 64,000 |
CF, cystic fibrosis; RTIICU, respiratory tract infection in intensive care unit.
According to the MLST Pasteur scheme.
CBr, resistance to carbapenems (imipenem and meropenem); CPr, resistance to cephems (ceftazidime and cefepime); FQr, resistance to fluoroquinolones (ciprofloxacin); AGr, resistance to aminoglycosides (amikacin and gentamicin); CSTr, resistance to colistin.
CST, colistin; NAC, N-acetylcysteine.